Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised trial of dolutegravir-based ART vs standard of care in children with HIV infection
2014-002632-14Phase 2Active
- Sponsor
- Penta Foundation
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dolutegravir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Penta Foundation. Started Jan 2016; status: active.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-002632-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002632-14.